Skip to main content

Table 3 Relation between log(hs-CRP) and cardiovascular events and mortality

From: Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes

 

Total population

Without manifest vascular disease

With manifest vascular disease

 

n = 1679

n = 481

n = 1124

 

HR (95% CI)

HR (95% CI)

HR (95% CI)

Myocardial infarction

n = 156

n = 25

n = 131

 Model I

1.16 (0.97–1.39)

1.27 (0.77–2.09)

1.21 (1.00–1.48)

 Model II

1.03 (0.85–1.25)

1.14 (0.67–1.93)

1.07 (0.86–1.32)

 Model III

1.14 (0.94–1.38)

1.15 (0.68–1.96)

1.07 (0.86–1.33)

Stroke

n = 85

n = 16

n = 61

 Model I

1.02 (0.81–1.30)

0.93 (0.53–1.62)

1.03 (0.93–1.15)

 Model II

0.89 (0.68–1.15)

0.70 (0.38–1.29)

0.89 (0.65–1.22)

 Model III

0.83 (0.64–1.08)

0.69 (0.37–1.28)

0.91 (0.66–1.25)

Cardiovascular events

n = 307

n = 50

n = 246

 Model I

1.16 (1.02–1.33)*

1.11 (0.79–1.56)

1.18 (1.03–1.37)*

 Model II

1.03 (0.90–1.19)

0.97 (0.67–1.39)

1.06 (0.91–1.25)

 Model III

1.08 (0.94–1.25)

0.99 (0.68–1.44)

1.07 (0.91–1.25)

Vascular mortality

n = 184

n = 29

n = 154

 Model I

1.36 (1.14–1.62)*

1.20 (0.77–1.86)

1.38 (1.14–1.66)*

 Model II

1.20 (1.00–1.45)*

1.18 (0.73–1.93)

1.18 (0.95–1.45)

 Model III

1.21 (1.01–1.46)*

1.24 (0.75–2.06)

1.18 (0.95–1.46)

All-cause mortality

n = 343

n = 64

n = 270

 Model I

1.10 (1.06–1.13)*

1.26 (0.94–1.69)

1.11 (1.06–1.17)*

 Model II

1.20 (1.04–1.37)*

1.06 (0.95–1.18)

1.20 (1.04–1.37)*

 Model III

1.26 (1.10–1.45)*

1.17 (0.83–1.63)

1.21 (1.03–1.41)*

  1. hs-CRP continuous, HR per 1 mg/l increase, hazard ratio (95% confidence interval)
  2. *statistically significant p < 0.05
  3. Model I: age + sex
  4. Model II: Model I + BMI, smoking, alcohol, non-HDL-c, micro-albuminuria
  5. Model III: Model II + lipid-lowering therapy, aspirin